Earlier we showed that RACK1 regulates growth of human colon cells by suppressing Src activity at G 1 and mitotic checkpoints. Here, we show that RACK1 also induces apoptosis of the cells, partly by inhibiting Src. In the intrinsic pathway, RACK1 inhibits expression of anti-apoptotic Bcl-2 and Bcl-X L , induces expression of proapoptotic Bim, targets Bim and Bax to the mitochondria, induces oligomerization of Bax (which requires Bim and inhibition of Src), depolarizes mitochondria membranes, releases cytochrome c, and activates caspases-9 and -3 and death substrates. Bax and Bim are required for RACK1-mediated mitochondrial cell death. RACK1-induced oligomerization of Bax is required for staurosporine-mediated cell death. RACK1 also induces apoptosis by blocking Src activation of the Akt cell survival pathway. This leads to activation of the transcription factor FOXO3, a potent inducer of apoptosis and G 1 arrest. Collectively, our results show that RACK1, partly by inhibiting Src, promotes mitochondrial cell death and blocks Akt-mediated cell survival. Thus, RACK1 inhibits growth and induces death of colon cells. Exploitation of these dual functions could lead to novel colon cancer therapies that mimic RACK1 function.
Introduction
Activated Src is emerging as an important survival factor that protects colon cancer cells from apoptosis and anoikis. Overexpression of a constitutively active c-Src mutant (Y527F) in SW480 colon cancer cells (of low intrinsic Src expression and activity) increased resistance to anoikis, whereas expression of c-src antisense in HT-29 cells (of high Src expression and activity) increased susceptibility to anoikis (Windham et al., 2002) . Consistent with these findings, simultaneous inhibition of the focal adhesion kinase (using a dominant-negative mutant) and Src (using the Src inhibitor PP2), enhanced detachment and apoptotic cell death in colon cancer cell lines (Golubovskaya et al., 2003) . Caspase-3 was activated and Akt (a serine/threonine kinase that promotes cell survival and blocks apoptosis) was downregulated in the apoptotic cells. When KM12L4A metastatic colon cancer cells were transfected with two distinct kinase-defective mutants of Src, both co-sensitized cells to apoptosis induced by Oxaliplatin and Fas activation, in part by activation of caspase-8 and Bid and inhibition of Bcl-X L (Griffiths et al., 2004) . Together, these results suggest that activated Src is a survival factor that protects colon cancer cells from apoptosis and anoikis. In all cases, elevated catalytic activity of Src was required to confer resistance to cell death. However, these studies rely on non-physiological means to manipulate Src activity in cells (over or underexpressing proteins or use of chemical inhibitors). None of them identifies a physiological mechanism by which Src activity is normally downregulated in colon cells (thereby allowing programed cell death to proceed), or an aberrant pathological mechanism by which Src is actually deregulated in colon cancer cells (thereby increasing resistance to cell death).
RACK1 is the founding member of a family of receptors for activated C kinase (PKC) collectively called RACKs (reviewed in Dorn and Mochly-Rosen, 2002) . Using a yeast two-hybrid assay, we identified RACK1 as a novel substrate and binding partner of Src and an endogenous inhibitor of Src kinase activity and cell growth (Chang et al., 1998 (Chang et al., , 2001 (Chang et al., , 2002 . We showed that RACK1 exerts its effect on colonic cell growth, in part by suppressing Src activity at G 1 and mitotic checkpoints (Mamidipudi et al., 2004a (Mamidipudi et al., , 2007 . We hypothesize that RACK1 regulates other aspects of cell growth.
Apoptosis is a universal cell suicide pathway mediated by the caspase family of intracellular cysteine proteases (reviewed in Makin and Dive, 2003; Shi, 2004; Danial and Korsmeyer, 2004; Green, 2005) . Caspase activation is triggered through the extrinsic and intrinsic pathways ( Figure 9 ). The extrinsic pathway is activated by engagement of death receptors on the cell surface. Binding of death ligands such as Fas and tumor necrosis factor (TNF) to their receptors induces formation of the death-induced signaling complex. Death-induced signaling complex in turn recruits caspases-8 and -10, and promotes the cascade of procaspase activation. The intrinsic pathway is triggered by various stresses, such as growth factor withdrawal, hypoxia, and DNA damage. Signals that are transduced in response to these stresses converge mainly on the mitochondria.
In the intrinsic pathway, the Bcl-2 family of proteins includes both pro-apoptotic (for example, Bim, Bax, and Bid) and anti-apoptotic (for example, Bcl-2 and Bcl-X L ) members (reviewed in Yip and Reed, 2008; Chipuk and Green, 2008) . The balance between these two subgroups helps determine the susceptibility of cells to a death signal. Following an apoptotic signal, pro-apoptotic proteins translocate to, and alter the permeability of the mitochondrial membrane, which leads to changes in mitochondrial membrane potential (MMP), cytochrome c release, production of reactive oxygen species, induction of the caspase adaptor Apaf-1, and activation of caspases-9 and -3. Anti-apoptotic proteins, which mostly reside in the outer mitochondrial membrane, counter these effects. The pro-apoptotic family members having only a BH3 domain (for example, Bim) act as triggers for distinct apoptosis pathways, whereas multidomain pro-apoptotic members (for example, Bax) are executioners of death orders relayed by the BH3-only proteins. After translocation, Bax inserts into the other mitochondrial membrane, oligomerizes with the aid of Bim and caspase-8-cleaved Bid, and releases cytochrome c by forming pores in the lipid bilayer.
Akt is a Ser/Thr kinase whose principal role in cells is to facilitate growth factor-mediated cell survival and to block apoptosis (Zhou et al., 2000) . The Akt pathway is frequently activated in human cancers and therefore has become a major target for cancer therapy. Activation of Akt by growth factors requires Src (Chen et al., 2001; Sharma et al., 2006; Trotman et al., 2006) . Akt blocks apoptosis by phosphorylating and inactivating caspase-9, the pro-apoptotic factor Bad, and the FOXO subfamily of forkhead transcription factors (Zhou et al., 2000; Ramaswamy et al., 2002) . Once phosphorylated, FOXO3 can no longer translocate to the nucleus in which it induces G 1 arrest (by inducing the CDK inhibitor p27) and apoptosis (Ramaswamy et al., 2002) . Similarly, phosphorylated Bad is also sequestered in the cytosol (Muslin and Xing, 2000) . Akt also facilitates cell survival by activating mTOR and S6 kinases and thereby accelerating protein translation (Zhou et al., 2000; reviewed in Cheng et al., 2005) .
We hypothesized that RACK1, in part by suppressing Src activity, induces apoptosis of colon cells. We found that RACK1 induces apoptosis, partly by suppressing Src activity in the intrinsic and Akt pathways.
Results

RACK1 induces apoptosis of human colon cells, partly by inhibiting Src activity
Earlier we showed that RACK1 regulates colonic cell growth, in part by suppressing Src activity at G 1 and mitotic checkpoints (Mamidipudi et al., 2004a (Mamidipudi et al., , 2007 . Another potential mechanism by which RACK1 could regulate growth is by inducing apoptosis. Thus, to determine whether RACK1 induces apoptosis of colon cells, we first overexpressed RACK1 in human colon carcinoma HT-29 cells and measured DNA content by flow cytometric analysis. During apoptosis, DNA breakup results in small fragments of free DNA in the nucleus, which are lost during fixation. As a result, apoptotic cells have a lower DNA content and staining with propidium iodide will show these cells in the sub-G 0 G 1 region. To determine whether potential RACK1 effects are dependent on RACK1's ability to inhibit Src activity, we used an RACK1 mutant (RACK1 Y228F/ Y246F) that lacks the Src phosphorylation and binding sites and consequently is no longer a substrate, binding partner, or an inhibitor of Src (Chang et al., 2002; Mamidipudi et al., 2004a Mamidipudi et al., , 2007 . We observed that 18% of cells overexpressing wild-type RACK1 were in the sub-G 0 G 1 region (Figure 1a ). In contrast, only 9% of mutant RACK1-overexpressing cells and 2% of vector transfectants were in this region. These results suggested that RACK1 induces apoptosis.
Although DNA cleavage is a hallmark of late apoptosis, loss of cell membrane phospholipid asymmetry with exposure of phosphatidylserine to the outer plasma membrane is an early event (Green, 2005) . Annexin V is a phospholipid-binding protein that binds phosphatidylserine with high affinity. Thus, we used annexin staining and flow cytometry as a sensitive, quantitative assay to detect cells in both early and late apoptosis ( Figure 1b) . We observed that many more RACK1-overexpressing cells were undergoing apoptosis (28%) than were untransfected (3%), vector-transfected (5%), or mutant RACK1-expressing cells (11%). Consistent with these results, depleting Src also induces apoptosis in nearly a third of cells. Previously, we showed that overexpression of wild type but not mutant RACK1 inhibits Src kinase activity in HT-29 cells (Mamidipudi et al, 2007) . Collectively, these results show that RACK1, in part through its inhibitory influence on Src, induces apoptosis of HT-29 cells. RACK1 expression also induced apoptosis of NIH 3T3 cells (data not shown).
RACK1 activates caspases through the intrinsic apoptotic pathway
On the basis of these observations, we next examined RACK1's influence on caspase activation through the intrinsic and extrinsic apoptotic pathways. We observed that overexpression of wild-type RACK1, and less so mutant RACK1, induced cleavage of caspases-9, -6, and -3, and the death substrate PARP in HT-29 cells (Figure 2a) . However, neither wild type nor mutant RACK1 cleaved caspase-8 (Figure 7a ). Caspase-3 activity, as measured in vitro by cleavage of the caspase-3 substrate DEVD, was approximately five-fold higher in wild-type RACK1 overexpressors and twofold higher in mutant RACK1 expressors than in control cells (Figure 2b ). Src depletion also induced cleavage of caspases-9, -3, and -6, and PARP (Figure 2c ). Together, these results suggested that RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright RACK1 works primarily through the intrinsic pathway to activate caspases in HT-29 cells, and it does so by both Src-dependent and independent mechanisms. RACK1 expression also induced cleavage of caspase-3 in NIH 3T3 cells (data not shown).
RACK1 modulates expression of some Bcl family members and the translocation of pro-apoptotic Bax and Bim to the mitochondria Our finding that RACK1 induces apoptosis through the intrinsic pathway in colon cells (Figure 2a ) and Bcl-X L , and increased expression of pro-apoptotic Bim, by a Src-dependent mechanism ( Figure 2d ). RACK1 had little effect on expression of pro-apoptotic Bax, Bik, Bid (Figure 7a ), Bmf, and Bad (data not shown). The effects of Src depletion were similar to those of RACK1 overexpression (Figure 2e ). These results suggest that a Src-dependent mechanism by which RACK1 induces apoptosis in the mitochondrial pathway is by inhibiting expression of anti-apoptotic gatekeepers and by selectively inducing expression of pro-apoptotic Bim. Next, we hypothesized that RACK1 induces the translocation of pro-apoptotic Bcl family members to the mitochondria. We focused on two proteins: Bax because it is a key 'executioner' that is required for most mitochondria-dependent cell death processes (reviewed in Yip and Reed, 2008; Chipuk and Green, 2008) , and Bim because it is a critical 'trigger' for mitochondrial cell death (see Discussion), and because its expression was induced by RACK1 overexpression and Src depletion (Figures 2d and e). To test our hypothesis, HT-29 cells were transfected with vector or wild type or mutant RACK1 and first immunostained with anti-Bax ( Figures  3a and b) . We observed that in control cells, Bax was located diffusely in the cytoplasm (row 1, columns 3 and 4) whereas in either wild type or mutant RACK1 overexpressors, Bax co-localized with mitochondria (rows 2 and 3, columns 3 and 4). This suggested that RACK1 induces the translocation of Bax to the mitochondria in an Src-independent manner. To confirm this using another approach, the mitochondria were separated from the nuclear and cytosolic fractions by differential centrifugation and assayed for the presence of Bax (Figure 3d ). In vector-transfected cells, Bax was localized predominantly in the cytosolic fraction whereas in RACK1 overexpressors, Bax was predominantly in the mitochondrial fraction. Cox 4, which is expressed exclusively in the mitochondria, was present in mitochondrial and not cytosolic fractions, thus confirming the purity of the cytosolic fractions. Hsp70, which is expressed exclusively in the cytosol, was used to confirm the purity of the mitochondrial fractions (for example, Figure 5b (Figure 3e ). Collectively, our results suggest that one mechanism by which RACK1 induces apoptosis is by selectively translocating proapoptotic Bax (through an Src-independent manner) and Bim (through an Src-dependent manner) to the mitochondria.
In response to apoptotic stimuli, cytosolic Bax undergoes a conformational change, which sensitizes it to activation and translocation to the mitochondria (Yethon et al., 2003) . Our finding that RACK1 induced the translocation of Bax prompted us to examine RACK1's influence on the activation of Bax Figure 2 RACK1 induces apoptosis through the intrinsic pathway by activating caspases and modulating expression of pro-and antiapoptotic BCL family members. HT-29 cells were transfected with the appropriate vector, GFP-RACK1 (RK), mutant GFP-RACK1 (mRK), scrambled src siRNA (sc), src siRNA-5 (src si-5), or src siRNA-6 (src si-6) as indicated. (a, c) Effect of RACK1 overexpression or Src depletion (respectively) on caspase cleavage; 20 mg of lysate protein were subjected to immunoblot analysis with antibody that recognizes RACK1, Src, the cleaved, uncleaved (pro-), or both forms of the specified caspase or the death substrate PARP as indicated. Data are representative of two or more independent experiments. (b) Effect of RACK1 overexpression on caspase-3 activity. Caspase-3 activity was measured by colorimetric detection (at 405 nm) of p-nitro-aniline (pNA) after cleavage from the caspase-3-specific peptide substrate DEVD-pNA. Values from triplicate plates for each transfection were averaged, and data shown represent mean values þ /À standard errors from three independent experiments. (d, e) Effect of RACK1 overexpression or Src depletion (respectively) on expression of pro-and antiapoptotic BCL family members; 20 mg of lysate protein were subjected to immunoblot analysis with anti-Bcl-2, Bcl-X L , Bim, Bax, Bik, or Apaf 1 as indicated. Data are representative of three or more independent experiments, except for Bcl-X L , which is representative of two experiments. (c, e) Immunoblot analysis with anti-tubulin showed that equivalent amounts of tubulin were present in each lane (not shown).
RACK1 promotes mitochondrial cell death
V Mamidiputdi and CA Cartwright ( Figure 4a , top panel). We observed that both wild type and mutant RACK1 promoted the activation of Bax, as assessed using the Bax monoclonal antibody 6A7 (which recognizes an epitope in Bax that is occluded in its inactive state and exposed in its active state). Thus, RACK1 induces the activation and translocation of Bax, both by Src-independent mechanisms.
RACK1, through its inhibitory influence on Src, and together with Bim induces the oligomerization of Bax at the mitochondria After translocation, Bax inserts into the outer mitochondrial membrane, in which it oligomerizes. Oligomerization of Bax is a critical step leading to permeabilization of the outer mitochondria membrane, possibly through formation of lipid pores (reviewed in Cytosolic (C) and mitochondrial (M) fractions were separated by differential centrifugation. Extracts were normalized to equivalent volume and subjected to immunoblot analysis with anti-Bax, Bim, Bik, or COX 4. COX 4, which is expressed exclusively in the mitochondria, was used to assess the purity of cytosolic fractions. Data are representative of three or more independent experiments.
RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright Yip and Reed, 2008; Chipuk and Green, 2008) . Our finding that RACK1 induced the translocation of both Bax and Bim to mitochondria (Figure 3 ) prompted us to examine RACK1's influence on the oligomerization of Bax (Figure 4a ). We observed that wild-type RACK1 induced more oligomerization of Bax in mitochondrial extracts than did mutant RACK1 (compare lanes 2 and 3). Depleting Bim abolished the RACK1-induced oligomerization of Bax (Figure 4b , top panel, compare lanes 2 and 4). Thus, wild-type RACK1, through its inhibitory influence on Src, and together with Bim induces the oligomerization of Bax at the mitochondria. In contrast, mutant RACK1 has little effect on oligomerization of Bax, presumably because this requires Bim (Figure 4b ) and the mutant RACK1 fails to induce the translocation of Bim to the mitochondria (Figures 3c and d ).
Bim and Bax are required for RACK1-mediated mitochondrial cell death To determine whether Bim and Bax are required for RACK1-mediated cell death, we overexpressed RACK1 in cells depleted of Bim or Bax, and assessed the effect on caspase-3 cleavage (Figures 4b and c, respectively) . Overexpression of RACK1 induced cleavage of caspase-3 (lane 2), consistent with the data shown in Figure 2a .
In contrast, depleting either Bim or Bax abolished the RACK1-induced oligomerization of Bax is required for staurosporine-mediated mitochondrial cell death Staurosporine (STS), a potent protein kinase C inhibitor with a broad spectrum of activity, is known to induce apoptosis through a mitochondria-mediated pathway (Meggio et al., 1995) . Thus, to determine whether RACK1 mediates STS-induced mitochondrial cell death, and if so, by what mechanism, we assessed the effect of STS treatment on RACK1-depleted cells ( RACK1, partly by suppressing Src activity, depolarizes mitochondrial membranes and releases cytochrome c To assess the effects of RACK1 on MMP, we used a fluorescent cationic dye, JC-1, which aggregates only in actively respiring mitochondria that have an intact transmembrane electrical potential (DCm). Qualitative evidence of mitochondrial depolarization (MMP loss) was observed by flow cytometry in wild type, and less so in mutant RACK1-overexpressing cells stained with JC-1 (data not shown). Quantitative analysis (Figure 6a ) showed a 34% loss of MMP in wild-type RACK1-overexpressing cells and a 10% loss of MMP in mutant RACK1-overexpressing cells when compared with vector-transfected cells. These results indicate that RACK1, mostly through its inhibitory influence on Src, dissipates DCm and depolarizes mitochondrial membranes. Src depletion reduced membrane potential to a level similar to that of RACK1 overexpression (Figure 6b ). Not surprisingly, overexpression of wildtype, but not mutant RACK1 (Figure 6c ) or depletion of Src (Figure 6d ), increased the release of cytochrome c from the mitochondria. Interestingly, RACK1 overexpression or Src depletion also induced expression of the cytosolic adaptor Apaf-1 (Figure 2d ), which is known to form the apoptosome in the presence of dATP and cytochrome c (thereby acting as an allosteric activator of caspase -9) and to regulate the intra-S-phase checkpoint induced by DNA damage (reviewed in Galluzzi et al., 2008; Oberst et al., 2008) .
To determine whether RACK1 and Src localize to the mitochondria, the mitochondria were separated from the nuclear and cytosolic fractions by differential centrifugation and assayed for the presence of the proteins. RACK1 and Src were detected in both cytosolic and mitochondrial fractions (data not shown). Next proteinase K, a nonspecific serine protease that cannot penetrate mitochondrial membranes, was used to determine whether RACK1 and Src were present inside the mitochondria or associate with the outer surface (Figure 6e ). Although some RACK1 (both endogenous and exogenous) was sensitive to proteinase K digestion, a significant fraction was not (lanes 4-6). The same was true for Src, as has been reported earlier (Miyazaki et al., 2003) . In contrast, Bcl-x L (an exposed surface Freshly isolated mitochondria (50 mg) were incubated with buffer or proteinase K (PK; 0.1 mg/ml) alone or together with Triton X-100 (TX-100; 1%) for 10 min on ice before the addition of phenylmethylsulfonyl fluoride (100 mM) and loading buffer. Immunoblot analyses were performed with anti-RACK1, Src, BCL-X L , or Cox 4 as indicated. Data are representative of three or more independent experiments. RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright protein that associates with the outer mitochondrial membrane) was completely digested by proteinase K. Cox-4 (an integral component of the inner mitochondrial membrane) was resistant to proteolysis by proteinase K. As expected, all proteins were degraded on the addition of the detergent Triton-X 100 (lanes 7-9). These results suggest that though a subpopulation of RACK1 and Src associates with the outer mitochondrial membrane, both proteins also reside within the mitochondria.
RACK1 does not induce apoptosis through the extrinsic pathway
To determine whether RACK1 induces apoptosis through the extrinsic pathway, we first examined the effect of RACK1 overexpression or Src depletion on activation of caspase-8 (a major initiator caspase in this pathway) and pro-apoptotic Bid, a downstream target of caspase-8 that facilitates Bax oligomerization in mitochondrial membranes. We observed that RACK1 overexpression did not induce the cleavage of caspase-8 and Bid (Figure 7a ), whereas Src depletion did (Figure 7b ). These results suggested that RACK1 does not induce apoptosis through the extrinsic pathway. To confirm this, we treated RACK1-depleted cells with death ligands TNF or Fas and assessed the effect on cleavage of caspase-8 and Bid. We observed that depleting RACK1 had no effect on the cleavage of caspase-8 and Bid by either TNF (Figure 7c , compare lanes 2 and 4) or Fas (not shown). Thus, RACK1 is not required for TNF-or Fas-mediated cell death.
RACK1 regulates Src activation of the Akt cell survival pathway
The Akt kinase exerts powerful anti-apoptotic activity by phosphorylating forkhead transcription factors and thereby preventing their translocation to the nucleus in which they would otherwise induce G 1 arrest and apoptosis. Src is involved in Akt activation, as evidenced by findings that (1) Akt activity induced by growth factors is significantly reduced in SYF cells lacking Src, Yes, and Fyn, and can be restored by introducing c-Src but not kinase-inactive Src back to these cells (Chen et al., 2001) , and (2) the interaction between the SH3 domain of Src family kinases and the proline-rich motif in the C-terminal regulatory region of Akt is required for tyrosine phosphorylation of Akt and its subsequent activation (Jiang and Qiu, 2003) .
Thus, we hypothesized that RACK1 regulates Src activation of the Akt cell survival pathway. To test this, we overexpressed wild type or mutant RACK1 or depleted Src in HT-29 cells and analyzed the effect on Akt signaling. For Akt to be fully activated and biologically functional, it must be sequentially phosphorylated by Src on Tyr 315 and 326 (which may help to open up the activation loop and stabilize the substrate), and then sequentially phosphorylated by other kinases on Thr 308 and Ser 473 (Chen et al., 2001; Sharma et al., 2006; Trotman et al., 2006) . Thus, to assess the influence of RACK1 and Src on Akt activity, we first examined their influence on phosphorylation of these activation sites. We found that overexpression of wild -type but not mutant RACK1, or depletion of Src, inhibited phosphorylation of these sites on Akt (Figures 8a and b, respectively) .
Next, we assessed the effect of RACK1 and Src on Akt activity, as measured by phosphorylation of the Akt substrate FOXO3, a member of the forkhead family of transcription factors. We observed that RACK1 overexpression resulted in striking dephosphorylation of FOXO3 by an Src-dependent mechanism (Figure 8a , panel 4, lane 2). Src depletion had a similar effect on dephosphorylation of FOXO3 (Figure 8b, panel 3, lanes  3 and 4) . Overexpression of wild type but not mutant RACK1 also induced the translocation of FOXO3 to the nucleus (Figure 8c , top panel, compare lane 2 with 1 and 3). Collectively, these results show that RACK1 regulates Src activation of the Akt cell survival pathway.
Discussion
Our results show that RACK1, partly by suppressing Src activity, promotes mitochondrial cell death and blocks Akt-mediated cell survival. This is the first study to define RACK1's pro-apoptotic function in colon RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright cells. The significance of these findings lies in discovery of a fundamental mechanism by which colon cells regulate their growth. We propose a model for RACK1 function in apoptosis (Figure 9 ). RACK1, partly by suppressing Src activity, triggers apoptosis through the intrinsic pathway (Figures 1 and 2 ) by modulating expression of Bcl-2 family members (Figure 2d ), targeting Bim and Bax to the mitochondria (Figure 3) , inducing the oligomerization of Bax (Figures 4 and 5) , depolarizing mitochondrial membranes, releasing cytochrome c (Figure 6 ), and activating caspases-9 and -3 and death substrates (Figures 2a and b) . RACK1 also blocks Src activation of the Akt cell survival pathway (Figure 8a ), resulting in translocation of the transcription factor FOXO3 to the nucleus (Figure 8c ) and induction of genes critical for apoptosis (for example, Bim, Figure 2d) .
The balance between pro-and anti-apoptotic proteins helps determine the susceptibility of cells to a death signal. Thus, Src, which seems to counter apoptosis by inducing expression of anti-apoptotic gatekeepers (Bcl-2 and Bcl-X L ), suppressing expression of pro-apoptotic Bim, inhibiting translocation of Bim to the mitochondria, stabilizing the polarity of mitochondrial membranes, inactivating caspases (-9, -8, and -3) and death substrates, and activating the Akt pathway, tips the balance significantly toward cell survival. RACK1, mostly by inhibiting Src activity, counters the Src effect, thus tipping the balance toward cell death. Therefore, RACK1 provides checks on Src, and together they maintain a balance between cell survival and death.
Our results showing that RACK1 expression in HT-29 colon carcinoma cells regulates Akt phosphorylation and activation (by inhibiting Src) and induces apoptosis are consistent with those of others showing that RACK1 expression in MCF-7 breast carcinoma cells inhibits Akt phosphorylation and activation (partly by sequestering Src) and decreases IGF-1-mediated protection from etoposide-induced apoptosis (Kiely et al., 2002) . Interestingly, we observed that RACK1 expression inhibits proliferation of HT-29 cells (Mamidipudi et al., 2004a (Mamidipudi et al., , 2007 , whereas Kiely et al. observed that RACK1 expression enhances proliferation of MCF-7 cells. The mechanisms by which RACK1 has opposing effects on the proliferation of different types of tumor cells has yet to be elucidated. Our findings are also consistent with those of others showing that sequestration of RACK1 into stress granules by type 1 stress suppresses apoptosis induced by type 2 stress (Arimoto et al., 2008) . Collectively, these studies show important mechanisms by which RACK1 promotes apoptosis.
Pro-apoptotic BCL family members that contain only BH3 domains (for example, Bim) have a critical role in triggering mitochondrial cell death. On activation by death signals, they translocate to the mitochondria and engage pro-survival Bcl-2 proteins, inactivating their function (reviewed in Yip and Reed, 2008; Chipuk and Green, 2008) . Bim is more potent than other BH3-only proteins in this inactivating function because it targets all the pro-survival proteins, unlike others, such as Noxa Model for RACK1 function in apoptosis. RACK1 induces apoptosis through the intrinsic pathway (partly by suppressing Src activity) by inhibiting expression of anti-apoptotic Bcl-2 and Bcl-X L , and by inducing the translocation of Bim and Bax to the mitochondria, the oligomerization of Bax, depolarization of mitochondrial membranes, release of cytochrome c, expression of the caspase adaptor Apaf-1, and activation of caspases-9 and -3 and death substrates. RACK1 also blocks Src activation of the Akt cell survival pathway.
RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright and Bad, which target only a subset. Bim and other BH3-only proteins activate Bax and Bak by displacing them from the Bcl-2 pro-survival proteins that sequester their active forms.
Recent studies show that neutralization of multiple pro-survival proteins by BH3-only pro-apoptotic proteins is necessary and sufficient to allow Bax-mediated apoptosis (Saito et al., 2000; Willis et al., 2007) . Studies with the BH3 mimetic drug ABT-737 are also consistent with this model (Konopleva et al., 2006; van Delft et al., 2006; Willis et al., 2007) . In healthy cells, Bax is regulated by binding through its exposed BH3 domain to both Bcl-X L and Mcl-1 (Antonsson et al., 1997) . Apoptosis is induced if and only if BH3-only proteins displace Bax from both these pro-survival guards by inserting their BH3 domain into a groove on the pro-survival proteins. This model emphasizes the central role of the pro-survival Bcl-2 proteins in inhibiting Bax and Bak, and the pivotal role of the BH3-only proteins in neutralizing the pro-survival proteins, thus allowing the oligomerization of Bax and Bak to proceed. Our results, showing that RACK1 translocates Bim to the mitochondria (Figure 3) where Bim is required for RACK1-induced oligomerization of Bax and for RACK1-mediated mitochondrial cell death (Figure 4b) , further shows the critical role of Bim in triggering apoptosis through the intrinsic pathway, and define a novel role for RACK1 in facilitating Bim translocation and function.
Our results also show that RACK1 induces the expression of Bim (Figure 2d ). Presumably one mechanism by which it does so is by blocking Src activation of the Akt pathway (Figure 8a) , thereby inducing the translocation of FOXO3 to the nucleus (Figure 8c ) where it transcriptionally upregulates Bim (Gilley et al., 2003) . Interestingly, Bim is a critical mediator of anoikis in epithelial cells (Reginato et al., 2003) , and v-Src suppresses Bim expression (Reginato et al., 2005) . Thus, our finding that RACK1 induces the expression of Bim is another example of how RACK1 confers checks and balances on Src activity and function in colon cells.
Although it was somewhat surprising to find both Src and RACK1 present within the mitochondria, others have shown that Src is present there (Miyazaki et al., 2003) . Cox-2, which is mostly mitochondrial in HT-29 cells (Liou et al., 2005) , is known to suppress apoptosis by inhibiting cytochrome c release and caspase activation (Sun et al., 2002) . We observed that overexpression of wild type but not mutant RACK1, or depletion of Src, inhibits Cox-2 activity (Supplementary Figure 1) . These results suggest that one mechanism by which RACK1 promotes cytochrome c release and caspase activation is by downregulating Cox-2 activity. Interestingly, we also observed that RACK1 co-immunoprecipitates with Bcl-2, Bax, and Bim in mitochondrial fractions (data not shown). Together, these observations suggest an intriguing role for RACK1 in regulating the activity of Src and apoptotic proteins at or in mitochondria. Additional studies are needed to further define the mitochondrial functions of RACK1 and Src.
Earlier we showed that RACK1 inhibits growth of colon cells by suppressing Src activity at G 1 and mitotic checkpoints (Mamidipudi et al., 2004a (Mamidipudi et al., , 2007 . Here, we show that RACK1 also inhibits growth by triggering apoptosis. These dual, complementary functions of RACK1 are linked: for example, RACK can arrest growth by inhibiting Src activity, repressing cyclin D1, and inducing the CDK inhibitor p27 at the G 1 /S boundary (Mamidipudi et al., 2004a) and by inducing the translocation of FOXO transcription factors to the nucleus (Figure 8c ) where they induce genes that are critical for apoptosis (for example, Bim, Figure 2d ; Gilley et al., 2003) , and also induce G 1 arrest (by inducing p27 and repressing cyclin D; Nakamura et al., 2000; Ramaswamy et al., 2002) .
Altered cell adhesion and detachment of cells from the extracellular matrix can trigger apoptosis or anoikis. RACK1 is known to regulate integrin-mediated cell adhesion (Buensuceso et al., 2001; Hermanto et al., 2002; Kiely et al., 2002 Kiely et al., , 2005 Cox et al., 2003; Mamidipudi et al., 2004b; Vomastek et al., 2007) . Moreover, RACK1 acts as a scaffolding protein to integrate adhesion and growth factor signaling necessary for cell migration. Interestingly, in cells expressing an IGF-IR mutant that is deficient in anti-apoptotic and transforming function, this scaffolding function of RACK1 is disrupted: RACK1 remains associated with b1 integrin but no longer associates with the IGF-IR, IRS-1, Shp2, Shc, or Src, and the cells no longer migrate (Kiely et al., 2005) . Thus, disruption of this essential scaffolding function of RACK1 may inhibit cell migration and increase susceptibility to apoptosis.
The significance of this work lies in discovery of fundamental mechanisms by which the growth of colon cells is regulated, by RACK1 suppression of a family of tyrosine oncogenic kinases at key cell-cycle checkpoints and during apoptosis. Exploitation of this dual function of RACK1 by development of RACK1 mimetics could be used to develop new and more powerful and selective strategies for treatment of colon cancer. Although targeting a protein-protein interaction for therapeutics is challenging, this approach has shown great promise in the treatment of common human diseases, including ischemic heart disease and cancer (Souroujon and Mochly-Rosen, 1998; Inagaki et al., 2006) . The RACK1-mediated gateway to apoptosis is ripe for new drug discovery for human colon cancer.
Materials and methods
Cell culture and transfections HT-29 and HEK293 cells were maintained in culture and transfected, as described (Mamidipudi et al., 2004a) . Where indicated, cells were serum starved for 24 h and treated with STS (200 nM; Sigma-Aldrich, St Louis, MO, USA) for 48-96 h, TNF-a (10 ng/ml; Sigma) for 48 h, or Fas (50 ng/ml; EMD Biosciences, San Diego, CA, USA) for 3 h.
Reagents
Plasmids pcDNA3-GFP, pcDNA3-GFP-RACK1, pcDNA3-GFP-RACK1Y228F/Y246F, pcDNA3, pcDNA3-HA-RACK1, RACK1 promotes mitochondrial cell death V Mamidiputdi and CA Cartwright pcDNA3-HA-RACK1Y228F/Y246F, pSuppressor-scrambledsiRNA, pSup-src-siRNA-5, and pSup-src-siRNA-6 were described earlier (Chang et al., 1998 (Chang et al., , 2001 (Chang et al., , 2002 Mamidipudi et al., 2004a Mamidipudi et al., , 2007 . Pooled siRNAs of RACK1, Bim, or Bax and non-targeting (scrambled) siRNA were commercially available (Dharmacon, Lafayette, CO, USA).
Immunoprecipitations, immunoblot analyses, and antibodies Immunoprecipitation and immunoblotting analyses were performed, as described (Mamidipudi et al., 2004a) . Primary antibodies included mouse monoclonal antibodies to Src (MAb 327; Lipsich et al., 1983) , RACK1, GFP (JL-8), Bax 3, Bax 6A7, cytochrome c (Pharmingen, San Diego, CA, USA), and tubulin (Sigma). Other primary antibodies included rabbit polyclonal antisera to caspases-3, -8, and -9, and PARP (recognize both the cleaved and uncleaved forms), procaspase-3, cleaved-3, cleaved-6 (Asp 162), pro-caspase-8, cleaved-8 (Asp 384), cleaved-PARP (Asp 214), Bim, Bax, Bik, Bid, Bcl-2, Bcl-X L , Apaf-1, Akt, phospho-Akt (Tyr326 or Ser473), phospho-FOXO3 (Ser253), and FOXO3 (Cell Signaling Technology, Beverly, MA, USA).
Flow cytometric analysis for DNA content and annexin-V and 7-amino actinomycin D staining For quantitation of cells in the sub-G 0 /G 1 region, HT-29 transfectants were analyzed for cellular DNA content as described (Mamidipudi et al., 2004a (Mamidipudi et al., , 2007 . For quantitation of cells in early and late apoptosis, transfectants were incubated with annexin-V-PE/7-AAD (7-amino actinomycin D) for 10 min at RT, according to the manufacturer's protocol (Pharmingen) and analyzed by flow cytometry. Cells ( 10 4 ) were analyzed by an FACScan cell sorter (Becton-Dickinson, Franklin Lakes, NJ, USA) using the FL2 channel for annexin V-PE and the FL4 channel for 7-AAD. Dot plots were prepared using FlowJo software (Tree Star, San Carlos, CA, USA).
Caspase-3 activity assays Caspase-3 activity was measured by colorimetric detection (at 405 nm) of p-nitro-aniline (pNA) after cleavage from the caspase-3 substrate DEVD-pNA (ApoAlert Caspase-3 Assay kit, Clontech, Mountain View, CA, USA). Briefly, lysates from 10 6 cells were incubated with DEVD-pNA (1 mM) for 1 h at 37 1C and the chromophore pNA was spectrophotometrically detected at l ¼ 405 nm (Gottlob et al., 1998) . Caspase-3 activity was quantified as described in the manual.
Immunocytochemical analysis
For fluorescent staining of mitochondria, cells were incubated with MitoTracker Deep Red 633 (100 nM) for 15-25 min at 37 1C according to the manufacturer's protocol (Molecular Probes, Eugene, OR, USA). Cells were fixed, permeabilized, and incubated with anti-Bax or Bim and then Alexa 350-conjugated goat anti-rabbit (Molecular Probes) as described (Mamidipudi et al., 2004a) . Proteins were detected by fluorescence microcopy.
Subcellular fractionations
For preparation of mitochondrial and cytosolic fractions, cell homogenates were centrifuged at 700 g for 10 min at 4 1C to separate nuclei (pellet), and supernatants were centrifuged at 10 000 g for 25 min at 4 1C to separate mitochondria (pellet) and cytosol (supernatant) (ApoAlert Cell Fractionation kit, Clontech; Kang et al., 2003) . Nuclear fractions were isolated per the manufacturer's protocol (Nuclear Extraction kit, Panomics, Fremont, CA, USA).
Bax oligomerization assays
For detection of Bax oligomers, mitochondrial-enriched fractions (50 mg) were incubated with the protein crosslinker 1,6-bismaleimidohexane (BMH; 5 mM) for 30 min at RT (Zhang et al., 2005) . Mitochondria were pelleted, dissolved in SDS sample buffer, and proteins were resolved by SDS-PAGE and analyzed by immunoblotting with anti-Bax.
Mitochondrial membrane potential determination
Changes in MMP (Dc) were monitored with a fluorescent cationic dye JC-1(5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolylcarbocyanine iodide). In healthy cells, JC-1 accumulates as aggregates in the mitochondria resulting in red fluorescence (lem ¼ 590 nm). However, in apoptotic and necrotic cells, JC-1 exists in monomeric form resulting in green fluorescence (lem ¼ 527 nm). A shift in fluorescence from 590 to 527 nm indicates loss of membrane potential. Cells were incubated with JC-1 (10 ng/ml), for 30 min at 37 1C and analyzed and quantified by flow cytometry (Kang et al., 2003) .
Proteinase K sensitivity assays Freshly isolated mitochondria (50 mg) were incubated in homogenizing buffer (without protease inhibitors) alone or in the presence of proteinase K (0.1 mg/ml) only or proteinase K plus Triton X-100 (1% final concentration). After a 10-min incubation on ice, 2 ml of phenylmethylsulfonyl fluoride (100 mM) was added to terminate proteolysis (Miyazaki et al., 2003; Chandra et al., 2004) . Proteins were analyzed by immunoblotting.
